Invest now

Onesource Specialty Pharma Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,588.70 -59.70 (-3.62%)Updated : 22 Jul 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 1,406.391,361.18446.01400.34
Other Net 15.02-12.37-5.91-8.50
Diluted Weighted Average Shares 11.4611.0411.4411.44
Depreciation/ Amortization 279.09273.8876.2965.68
Total Extraordinary Items 0.00-0.69-25.47-384.19
Operating Income 15.2083.68-274.09-361.63
Net Income -73.80-17.97-391.17-799.83
Income Availableto Com Excl Extra Ord -73.80-17.28-365.70-415.65
Other Operating Expenses Total 430.470.660.400.76
Net Income Before Taxes -91.96-67.07-365.70-415.65
Net Income After Taxes -73.80-17.28-365.70-415.65
Income Availableto Com Incl Extra Ord -73.80-17.97-391.17-799.83
Costof Revenue Total 444.65471.1690.6440.50
Gross Profit 976.94973.7081.28-1.78
Interest Inc( Exp) Net- Non- Op Total -122.18-138.15-79.89-45.51
Unusual Expense( Income) 9.93110.74115.94145.14
Diluted Net Income -73.80-17.97-391.17-799.83
Provisionfor Income Taxes -18.16-49.790.000.00
period Type ----
Net Income Before Extra Items -73.80-17.28-365.70-415.65
Total Revenue 1,421.591,444.85171.9238.71
period Length 12.0012.0012.0012.00
Revenue 1,421.591,444.85171.9238.71
Selling/ General/ Admin Expenses Total 242.25502.69162.73148.27
Diluted Normalized EPS -5.884.97-21.32-23.64
Diluted EPS Excluding Extra Ord Items -6.44-1.57-31.96-36.32
Gain( Loss)on Saleof Assets --0.23-5.810.00
Research Development -2.05--
DPS- Common Stock Primary Issue --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
4,721.50+33.45(0.71%)
13,631.95+38.65(0.28%)
287.25+0.55(0.19%)
1,028.20-16.05 (-1.54%)
1,242.00-15.85 (-1.26%)